(BOXX) Alpha Architect 1-3 Month - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US02072L5654 • Ultrashort Bond
BOXX: Box Spreads, Options Strategies, Short-Term Maturities
The Alpha Architect 1-3 Month Box ETF (BATS: BOXX) is an ultrashort bond ETF designed to generate income through a unique options-based strategy. Under normal market conditions, the fund allocates at least 80% of its total assets to box spreads, which are exchange-listed options strategies. These box spreads are structured to have a weighted average maturity of less than 90 days, aligning with the funds focus on short-term instruments. The strategy aims to capture the difference between the prices of put and call options with differing strike prices, leveraging the time decay of options to generate returns while minimizing exposure to interest rate fluctuations.
As of the latest data, the ETF trades on the BATS exchange under the ticker symbol BOXX and is categorized as an ultrashort bond fund. It has attracted significant assets under management (AUM) of approximately $5.778 billion, indicating strong investor interest in its low-duration, income-focused approach. The funds average trading volume over the past 20 days is about 1,035,900 shares, reflecting moderate liquidity. Its current price is 111.87, with key moving averages (SMA 20: 111.64, SMA 50: 111.37, SMA 200: 109.80) suggesting a stable uptrend. The Average True Range (ATR) of 0.05 highlights the ETFs low volatility, consistent with its ultrashort bond classification.
3-Month Forecast: Based on the technical and fundamental data, BOXX is expected to maintain its stable performance. The tight trading range indicated by the low ATR of 0.05 suggests minimal price fluctuations. The moving averages (SMA 20, SMA 50, SMA 200) are converging, signaling a period of range-bound trading with a slight upward bias. The funds AUM of $5.778 billion underscores its established presence in the ultrashort bond space, supporting its ability to maintain liquidity and stability. Overall, BOXX is projected to trade within a narrow range of 111.20 to 112.50 over the next three months, with a focus on income generation through its box spread strategy.
Additional Sources for BOXX ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BOXX ETF Overview
Market Cap in USD | 5,778m |
Category | Ultrashort Bond |
TER | 0.19% |
IPO / Inception | 2022-12-27 |
BOXX ETF Ratings
Growth Rating | 38.2 |
Fundamental | - |
Dividend Rating | 1.12 |
Rel. Strength | 4.1 |
Analysts | - |
Fair Price Momentum | 106.64 USD |
Fair Price DCF | - |
BOXX Dividends
Dividend Yield 12m | 0.26% |
Yield on Cost 5y | 0.29% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
BOXX Growth Ratios
Growth Correlation 3m | 99.9% |
Growth Correlation 12m | 100% |
Growth Correlation 5y | 100% |
CAGR 5y | 5.04% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 0.94 |
Alpha | 0.71 |
Beta | 0.002 |
Volatility | 3.72% |
Current Volume | 612.3k |
Average Volume 20d | 900.2k |
As of May 06, 2025, the stock is trading at USD 111.96 with a total of 612,345 shares traded.
Over the past week, the price has changed by +0.10%, over one month by +0.39%, over three months by +1.06% and over the past year by +4.91%.
Partly, yes. Based on ValueRay Analyses, Alpha Architect 1-3 Month (BATS:BOXX) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 38.16 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BOXX as of May 2025 is 106.64. This means that BOXX is currently overvalued and has a potential downside of -4.75%.
Alpha Architect 1-3 Month has no consensus analysts rating.
According to ValueRays Forecast Model, BOXX Alpha Architect 1-3 Month will be worth about 115.2 in May 2026. The stock is currently trading at 111.96. This means that the stock has a potential upside of +2.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 115.2 | 2.9% |